Related Experiment Video
Updated: Aug 15, 2025

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes
Published on: December 16, 2022
Cardiac Contractility Modulation: A Technical Review
1University of Kentucky Division of Cardiovascular Medicine, Lexington, KY, USA.
Abstract:
Therapeutic options for the management of systolic congestive heart failure involving newer implantable device technologies that were not previously available now exist. Cardiac contractility modulation (CCM) has been shown to benefit patients with class III systolic heart failure with an ejection fraction of 25%-45% not indicated for biventricular pacing. Despite the increased use of CCM, there is a significant knowledge deficit in the general electrophysiology community regarding its clinical management. This significantly relates to the different functional characteristics of CCM compared to those encountered in traditional cardiac rhythm management devices. Improved evaluation and troubleshooting of CCM for therapeutic effect will benefit from advanced education. The goal of this review is to present pertinent technical aspects relating to CCM therapy management in a simplified fashion, all the while providing a clinical context to facilitate greater expertise.
Related Concept Videos
Pathophysiology of Cardiac Performance
Cardiomyopathy II: Dilated Cardiomyopathy
Specialized Characteristics of Cardiac Muscles
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy...
Heart Failure Drugs: Inotropic Agents
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy

